Klotho Neurosciences, Inc. Warrant

Klotho Neurosciences has partnered with AAVnerGene to enhance gene therapy manufacturing processes for neurological disease treatments, focusing on more efficient and cost-effective AAV vector technologies.

Klotho Neurosciences, a biotechnology company focused on developing cell and gene therapies for neurodegenerative diseases, will present at the Biotech Showcase 2025 conference during the J.P. Morgan Healthcare Week in San Francisco.